- SIDE EFFECTS
0.5mg x 8 tablets (Pfizer)
CABERGOLINE BASIC INFORMATION
Cabergoline in the Dostinex format works as an agonist for the chemical dopamine which is found in the brain. Dopamine is involved in the formation of epinephrine as well as the inhibition of the release of prolactin throughout our pituitary glands. Prolactin can unfortunately cause a number of side effects especially in huge amounts.
When we adjust our hormonal balance through the use of anabolic steroids excess prolactin can be produced which can cause some related side effects. Managing these side effects requires a product like Cabergoline in the Dostinex formula.
Athletes can reduce prolactin extremely efficiently and ensure proper sexual function throughout their entire training regiment. For athletes that regularly use Nandrolone and Trenbolone-based steroids this product is a good add to any cycle. The recommended dosage on this product for men and women is 25-.5 mg each week.
Adverse reactions of Cabergoline are manifested in cases of individual intolerances to the active agent or significant increases of recommended dosages. Excessive dosage leads to a rapid decrease in the concentration of prolactin in the body, which is fraught with reduced appetite, insomnia, dizziness, constipation, nausea, skin rash, labored breathing, depressed mood, peripheral oedema, low blood pressure. Before using Cabergoline, it is necessary to test for the concentration of prolactin in the body.
Cabergoline is often used in sports in the traditional regimen of 0.25 mg of the active agent once every 4 days. When the concentration of prolactin significantly exceeds the normal values, it is used at 0.25 mg once every two days until the level of the peptide hormone is reduced to the normal level, after which the drug is taken in the traditional regimen. In addition to the abovementioned positive properties of Cabergoline, the use of the drug during a steroid cycle eliminates adverse reactions in the form of face swelling and excessive fluid accumulation in muscle tissue.
The drug can be used in sports not only during an anabolic steroid cycle with high progestin activity, but Cabergoline can also enhance the effect of steroid substances and improve the users’ sex life. In this case, 0.5 mg of the active agent is used every 10 days. Cabergoline can be used as an additional drug during post-cycle therapy if a high concentration of prolactin is observed in the body. The optimal dosages are 0.25 mg once every seven days throughout PCT.